UBS raises Johnson & Johnson price target to $320 from $280
UBS maintained Johnson & Johnson at Buy and raised its price target to $320.00 per share from $280.00, according to TradingView News ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.